ProShares Ultra Nasdaq Biotechnology ETF Has Returned 22.8% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Mon Dec 15, 9:19AM CST
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on October 21st, 2014 at $104.76. In approximately 2 months, ProShares Ultra Nasdaq Biotechnology ETF has returned 22.84% as of today's recent price of $128.68.
BIB: 118.31 (-2.94)
25.1% Return Seen to Date on SmarTrend ProShares Ultra Nasdaq Biotechnology ETF Call (BIB)
Comtex SmarTrend(R) - Fri Dec 05, 4:55PM CST
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on October 21st, 2014 at $104.76. In approximately 2 month, ProShares Ultra Nasdaq Biotechnology ETF has returned 25.05% as of today's recent price of $131.00.
BIB: 118.31 (-2.94)
Shares of BIB Up 23.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 28, 11:03AM CST
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on October 21st, 2014 at $104.76. In approximately 1 month, ProShares Ultra Nasdaq Biotechnology ETF has returned 23.28% as of today's recent price of $129.14.
BIB: 118.31 (-2.94)
Vargatef cleared in Europe for lung cancer
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 8:23AM CST
HTBX: 4.00 (-0.08), BIB: 118.31 (-2.94), INCY: 71.62 (-0.52), PFE: 30.67 (-0.19), IBB: 293.67 (-3.99), DRGS: 52.00 (unch), BIND: 5.56 (+0.01), BMY: 57.69 (-0.86), GSK: 41.92 (+0.62), ONTY: 1.76 (-0.14), ECYT: 5.88 (-0.16), BIS: 50.05 (+1.20), CLVS: 53.28 (+0.09), AZN: 69.56 (-0.18), MRK: 56.80 (-0.15), ARIA: 6.08 (-0.02), IRY: 46.98 (+0.45), IXJ: 99.16 (-0.64), FPRX: 21.92 (+0.07)
UniQure sets price record with Glybera
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 2:33PM CST
BIS: 50.05 (+1.20), QURE: 14.79 (+0.15), BIB: 118.31 (-2.94), ALXN: 177.73 (-5.48), IBB: 293.67 (-3.99)
China mulling eliminating drug price controls
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 6:17AM CST
EWH: 20.28 (-0.20), PEK: 43.11 (+1.69), CNXT: 31.13 (+0.20), KBA: 44.53 (+1.69), BIB: 118.31 (-2.94), CQQQ: 34.29 (-0.66), IBB: 293.67 (-3.99), DRGS: 52.00 (unch), CHXF: 50.82 (+0.07), YINN: 29.43 (-0.24), FXP: 49.07 (+0.25), EWHS: 27.40 (unch), PGJ: 27.03 (-0.66), FCA: 22.14 (-0.11), YAO: 27.08 (-0.08), FCHI: 48.91 (-0.24), ASHR: 34.79 (+1.24), ASHS: 37.76 (+0.55), GXC: 76.59 (-0.45), FXI: 39.36 (-0.09), XPP: 60.51 (-0.25), KWEB: 32.10 (-0.86), ECNS: 45.10 (-0.35), TAO: 20.71 (-0.10), CHNA: 33.75 (+1.77), QQQC: 21.30 (-0.29), CHIX: 14.61 (+0.06), KFYP: 64.09 (unch), HAO: 26.01 (-0.18), MCHI: 47.77 (-0.18), CHIM: 15.41 (+0.42), YANG: 14.28 (+0.10), BIS: 50.05 (+1.20), CHIQ: 12.56 (-0.03), CHIE: 13.11 (-0.19), FHK: 38.71 (-0.08), CHII: 13.46 (-0.02), YXI: 30.37 (+0.20), CN: 33.27 (+0.25)
Drug makers face pushback on pricey meds
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 7:18AM CST
ABT: 43.40 (-0.06), BIIB: 325.13 (-10.67), BIB: 118.31 (-2.94), PFE: 30.67 (-0.19), AMGN: 159.44 (-0.16), IBB: 293.67 (-3.99), LLY: 69.26 (-0.41), DRGS: 52.00 (unch), GSK: 41.92 (+0.62), BMY: 57.69 (-0.86), CELG: 110.09 (-1.79), JNJ: 102.76 (-1.20), ESRX: 79.45 (-3.32), BIS: 50.05 (+1.20), MRK: 56.80 (-0.15), AZN: 69.56 (-0.18), CVS: 92.31 (+2.44), ABBV: 65.25 (-0.37), SNY: 45.38 (+0.98), IRY: 46.98 (+0.45), IXJ: 99.16 (-0.64), NVS: 91.65 (+0.01)
Histogenics on deck for IPO
Seeking Alpha - at Seeking Alpha - Mon Nov 24, 3:30PM CST
IPO: 22.40 (-0.17), BIS: 50.05 (+1.20), BIB: 118.31 (-2.94), IBB: 293.67 (-3.99)
CB Pharma on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 10:46AM CST
IPO: 22.40 (-0.17), BIS: 50.05 (+1.20), BIB: 118.31 (-2.94), CNDO: 2.05 (+0.05), IBB: 293.67 (-3.99), DRGS: 52.00 (unch), IXJ: 99.16 (-0.64), IRY: 46.98 (+0.45)
CF Foundation sells royalties for $3.3B
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 7:03AM CST
BIS: 50.05 (+1.20), VRTX: 110.86 (-2.02), BIB: 118.31 (-2.94), IBB: 293.67 (-3.99), DRGS: 52.00 (unch), IXJ: 99.16 (-0.64), IRY: 46.98 (+0.45)
Global drug tab will breach trillion dollar mark this year
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 6:41AM CST
BIS: 50.05 (+1.20), IMS: 25.49 (+0.12), PCYC: 129.56 (+1.12), GILD: 100.46 (-2.70), BIB: 118.31 (-2.94), IBB: 293.67 (-3.99), AMGN: 159.44 (-0.16), DRGS: 52.00 (unch), IXJ: 99.16 (-0.64), IRY: 46.98 (+0.45)
Second Sight begins trading today
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 8:42AM CST
IPO: 22.40 (-0.17), EYES: 13.76 (-0.35), BIS: 50.05 (+1.20), BIB: 118.31 (-2.94), IBB: 293.67 (-3.99)
Neothetics on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 12:46PM CST
IPO: 22.40 (-0.17), BIS: 50.05 (+1.20), BIB: 118.31 (-2.94), IBB: 293.67 (-3.99)
S1 Biopharma set for IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 12:20PM CST
IPO: 22.40 (-0.17), BIS: 50.05 (+1.20), BIB: 118.31 (-2.94), IBB: 293.67 (-3.99), SXB: ()
PRA Health Sciences on deck for IPO
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 1:06PM CST
IPO: 22.40 (-0.17), BIS: 50.05 (+1.20), BIB: 118.31 (-2.94), IBB: 293.67 (-3.99), DRGS: 52.00 (unch), PRAH: 23.65 (+0.66), IXJ: 99.16 (-0.64), IRY: 46.98 (+0.45)
NeuroDerm on deck for IPO
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 12:38PM CST
IPO: 22.40 (-0.17), BIS: 50.05 (+1.20), BIB: 118.31 (-2.94), IBB: 293.67 (-3.99), NDRM: 6.34 (-0.47)
FibroGen on deck for IPO
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 12:46PM CST
IPO: 22.40 (-0.17), BIS: 50.05 (+1.20), BIB: 118.31 (-2.94), AZN: 69.56 (-0.18), IBB: 293.67 (-3.99), FGEN: 29.07 (+0.03)
Jaguar Animal Health postpones IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 10:57AM CST
IPO: 22.40 (-0.17), JAGX: (), BIS: 50.05 (+1.20), PARN: 3.70 (-0.16), BIB: 118.31 (-2.94), IBB: 293.67 (-3.99)